Psyched Wellness Launches Calmer, a 2x Version of Calm and an Enhanced Flavour Profile for Calm
Rhea-AI Summary
Psyched Wellness (OTCQB: PSYCF) launched Calmer, a 2x potency version of its flagship Calm dietary supplement derived from Amanita Muscaria, and rolled out an enhanced flavour profile for Calm in both 30 ml and 60 ml formats that reduces mushroom taste while keeping potency.
The launch coincides with a site-wide 40% Black Friday promotion (excluding merch) through December 1, 2025. Management says R&D concentrated AME-1 to increase potency without compromising experience. The company is expanding route-to-market partnerships across Canada and the United States and invites distributors to contact sales@psyched-wellness.com.
Positive
- None.
Negative
- None.
Key Figures
Market Reality Check
Peers on Argus
Peers showed mixed moves: MUSLF down 18.89%, BABYF down 7.57%, while MTTCF gained 7.14% and others were flat. PSYCF’s 24.17% rise appears stock-specific rather than sector-driven.
Historical Context
| Date | Event | Sentiment | Move | Catalyst |
|---|---|---|---|---|
| Oct 09 | Investor update | Neutral | +4.0% | Outlined AME-1 product, safety, patent, and regulatory progress for investors. |
This announcement builds on prior developments around Psyched Wellness’s Amanita muscaria-based products. On Oct 9, 2025, the company issued an investor update highlighting progress on its AME-1 extract, including product launches, a genotoxicity study, and patent and regulatory steps. That news saw a 4% 24-hour price move. Today’s launch of Calmer, a 2x potency version of Calm with an improved flavour profile and a Black Friday promotion, continues the commercialization focus of these Amanita-derived supplements.
Market Pulse Summary
This announcement highlights Psyched Wellness’s continued commercialization of its Amanita muscaria-based line, adding Calmer, a 2x potency version of Calm, alongside an improved flavour profile for existing Calm formats. A Black Friday discount of 40% through December 1, 2025 aims to drive trial and repeat use. In context of the prior October investor update on AME-1 progress, investors may watch sales traction, regulatory developments, and future product extensions as key metrics.
Key Terms
amanita muscaria medical
AI-generated analysis. Not financial advice.
Toronto, Ontario--(Newsfile Corp. - November 27, 2025) - Psyched Wellness Ltd. (CSE: PSYC) (OTCQB: PSYCF) (FSE: 5U9) (the "Company" or "Psyched"), a life sciences company specializing in the production and distribution of dietary supplements derived from the Amanita Muscaria mushroom, is pleased to announce the launch of Calmer, a new product offering that delivers twice the potency of its flagship product, Calm.
The Company has also enhanced the flavour profile of Calm in both the 30 ml and 60 ml formats, reducing the mushroom taste while maintaining potency and consumer experience. The launch coincides with Psyched's Black Friday promotion, offering customers a
Jeffrey Stevens, CEO of Psyched Wellness, commented:
"We are thrilled to launch Calmer, a 2x version of Calm. We listened to the feedback of our monthly subscribers, who expressed a desire for a more potent version. After months of R&D, our team successfully concentrated AME-1 without compromising potency or experience. In addition to R&D on Calmer, we worked on improving the flavour profile of Calm, resulting in a smoother taste while maintaining the potency and experience."
Psyched Wellness continues to expand its route-to-market partnerships across Canada and the United States. Interested distributors or retailers are encouraged to contact the Company at **sales@psyched-wellness.com**.
Psyched Wellness will be growing their route-to-market partnerships, throughout the nation. If you are interested in distributing/listing Calm, please reach out to sales@psyched-wellness.com.
For further information, please contact:
Jeffrey Stevens
Chief Executive Officer
Psyched Wellness Ltd.
Tel: 647-400-8494
Email: jstevens@psyched-wellness.com
Neither the Canadian Securities Exchange nor its Regulation Services Provider have reviewed or accept responsibility for the adequacy or accuracy of this release.
About Psyched Wellness Ltd.:
Psyched Wellness Ltd. is a Canadian-based dietary supplements company dedicated to researching and producing consumer packaged goods product derived from our proprietary extract of the Amanita Muscaria mushroom, AME-1.
Cautionary Statement Regarding Forward-Looking Information
This press release contains "forward-looking information" within the meaning of applicable Canadian securities legislation. These statements relate to future events or future performance. The use of any of the words "could", "proposed", "intend", "expect", "believe", "will", "projected", "estimated" and similar expressions and statements relating to matters that are not historical facts are intended to identify forward-looking information and are based on the Company's current belief or assumptions as to the outcome and timing of such future events. The forward-looking information and forward- looking statements contained herein include, but are not limited to, statements regarding: the ability of the Company to achieve its scheduled production runs; Company's expectations regarding regulatory compliance and market introduction of AME-1; the safety of Amanita Muscaria consumption and the safety and purity of any extracts thereof; and the uses and potential benefits of Amanita Muscaria.
Forward-looking information in this news release are based on certain assumptions and expected future events, namely: the Company's ability to continue as a going concern; the Company's ability to continue to develop its mushroom-derived products and associated consumer packaged goods; continued approval of the Company's activities by the relevant governmental and/or regulatory authorities; continued support of safety and risk assessments to support the Company's evaluation of its products; and the continued growth of the Company.
These statements involve known and unknown risks, uncertainties and other factors, which may cause actual results, performance or achievements to differ materially from those expressed or implied by such statements, including but not limited to: the potential inability of the Company to continue as a going concern; risks associated with potential governmental and/or regulatory action with respect to the Company's operations; competition within the market; risks with respect to the safety of Amanita Muscaria consumption and the safety and purity of any extracts thereof; and the risk that there is no potential benefit of Amanita Muscaria consumption.
Readers are cautioned that the foregoing list is not exhaustive. Readers are further cautioned not to place undue reliance on forward-looking statements, as there can be no assurance that the plans, intentions or expectations upon which they are placed will occur. Such information, although considered reasonable by management at the time of preparation, may prove to be incorrect and actual results may differ materially from those anticipated.
Forward-looking statements contained in this news release are expressly qualified by this cautionary statement and reflect the Company's expectations as of the date hereof and are subject to change thereafter. The Company undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, estimates or opinions, future events or results or otherwise or to explain any material difference between subsequent actual events and such forward-looking information, except as required by applicable law.
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/276093
FAQ
What is Calmer from Psyched Wellness (PSYCF) and how does it differ from Calm?
When is Psyched Wellness's Black Friday discount for PSYCF product purchases valid?
Which Calm formats received a flavour update from Psyched Wellness (PSYCF)?
What active ingredient did Psyched Wellness concentrate in Calmer?
How can distributors or retailers contact Psyched Wellness about listing Calm or Calmer?
Does the Calmer launch change Psyched Wellness's product availability or markets (PSYCF)?
